RXDX
VOYA Investment Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-122,504
| Closed | -$13.1M | – | 3050 |
|
|
2023
Q1 | $13.1M | Buy |
122,504
+51,761
| +73% | +$5.55M | 0.01% | 641 |
|
|
2022
Q4 | $7.78M | Buy |
70,743
+18,658
| +36% | +$2.05M | 0.01% | 813 |
|
|
2022
Q3 | $3.07M | Buy |
52,085
+40,731
| +359% | +$2.4M | ﹤0.01% | 1157 |
|
|
2022
Q2 | $321K | Sell |
11,354
-406
| -3% | -$11.5K | ﹤0.01% | 2129 |
|
|
2022
Q1 | $444K | Buy |
11,760
+865
| +8% | +$32.7K | ﹤0.01% | 1986 |
|
|
2021
Q4 | $431K | Buy |
+10,895
| New | +$431K | ﹤0.01% | 2105 |
|